WaveMan · Form 4
Eansor Norman David insider trades
> Search tickers & screens ⌘K
LIVE

Eansor Norman David insider trades

Eansor Norman David has filed 7 Form 4s with the SEC that we hold, for Marker Therapeutics, Inc. (MRKR) (Director) and BIO-TECHNE Corp (TECH) (President-Protein Sciences). Across all of them we count 1 purchase worth $250.0K and 11 sales worth $14.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 9,043 shares of BIO-TECHNE Corp worth $4.6M, dated 2021-11-12. The first filing on our record is dated 2021-08-10 and the latest 2025-11-19.

Marker Therapeutics, Inc. (MRKR)

Director · 4 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-03-16P, purchase reported on Form 414,285$250.0K2023-06-08

BIO-TECHNE Corp (TECH)

President-Protein Sciences · 3 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-31S, sale reported on Form 41,538$773.7K2021-09-02
2021-11-12S, sale reported on Form 4401$203.0K2021-11-16
2021-11-12S, sale reported on Form 4700$352.9K2021-11-16
2021-11-12S, sale reported on Form 4200$101.0K2021-11-16
2021-11-12S, sale reported on Form 48,989$4.5M2021-11-16
2021-11-12S, sale reported on Form 4537$270.7K2021-11-16
2021-11-12S, sale reported on Form 4400$202.0K2021-11-16
2021-11-12S, sale reported on Form 44,054$2.0M2021-11-16
2021-11-12S, sale reported on Form 49,043$4.6M2021-11-16
2021-11-12S, sale reported on Form 42,535$1.3M2021-11-16
2021-11-12S, sale reported on Form 4300$150.9K2021-11-16
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1270905) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms